Retraction

Development of a highly sensitive chemiluminescence immunoassay using a novel signal-enhanced detection system for quantitation of durvalumab, an immune-checkpoint inhibitor monoclonal antibody used for immunotherapy of lung cancer

Paper Information

Record ID:
66053
Publication Date:
June 13, 2023
Retraction Date:
November 13, 2023 (2.0 years years ago)
Article Type:
Publisher:
Elsevier - Cell Press
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:

Retraction Details

Retraction Reason:

Duplication of/in Article

Nature of Retraction:

Retraction

Citations (0)

0
Total Citations
0
Post-Retraction
0
Pre-Retraction
0
Same Day
No citations found for this paper.